Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine.
Th17 cells are major effector T cells in the intestine, but the regulation of their tissue tropism within the gut is poorly understood. We investigated the roles of vitamin A and retinoic acid in generation of inflammatory Th17 cells with distinct tissue tropisms within the intestine. We found that Th17 cells with distinct tissue tropisms and pathogenic activities are generated depending on the available concentration of retinoic acid (RA). In contrast to the widespread perception that RA would suppress the generation of Th17 cells, we provide evidence that RA is actually required for generation of Th17 cells with specific tissue tropisms within the gut. Th17 cells induced at suboptimal serum concentrations of RA migrated and induced moderate inflammation mainly in the large intestine, whereas the Th17 cells induced with optimal levels of exogenous RA (approximately 10 nM) migrated to the small intestine and induced more severe inflammation. The Th17 cells, induced in the presence or absence of RA, differentially expressed the trafficking receptors CCR9 and alpha4beta7. CCR9 is required for Th17 cell migration to the small intestine, whereas alpha4beta7 is required for the migration of Th17 cells throughout the whole intestine. Our results identified RA as a major signal that regulates the generation of gut Th17 cells with distinct capacities in migration and inflammatory activities. The results indicate also that specific gut tropism of Th17 cells is determined by the combination of trafficking receptors regulated by the RA signal.
Wang
Chuanwu
C
Laboratory of Immunology and Hematopoiesis, Department of Comparative Pathobiology, Purdue Cancer Center, Purdue University, West Lafayette, IN 47907, USA.
Kang
Seung G
SG
HogenEsch
Harm
H
Love
Paul E
PE
Kim
Chang H
CH
D000818:Animals; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000235:genetics / Q000276:immunology*; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D020381:Interleukin-17 / Q000096:biosynthesis* / Q000502:physiology; D007421:Intestine, Small / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D018655:Lymphocyte Count; D051379:Mice; D008806:Mice, Inbred AKR; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D016201:Receptors, Lymphocyte Homing / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D012720:Severity of Illness Index; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000378:metabolism / Q000473:pathology* / Q000637:transplantation; D014212:Tretinoin / Q000502:physiology*
C098680:Il17a protein, mouse; D020381:Interleukin-17; D016201:Receptors, Lymphocyte Homing; D014212:Tretinoin
Gut. 2009 Sep;58(9):1207-17
18483078
Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G827-38
16537974
Gut. 2003 Jan;52(1):65-70
12477762
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10056-9
1438194
Blood. 2001 Nov 1;98(9):2626-32
11675330
Semin Immunol. 2009 Feb;21(1):8-13
18849172
Blood. 2008 Feb 1;111(3):1013-20
17951529
Cell. 2006 Sep 22;126(6):1121-33
16990136
Gastroenterology. 2007 Mar;132(3):966-81
17324406
Inflamm Bowel Dis. 2006 May;12(5):382-8
16670527
J Clin Invest. 2002 Oct;110(8):1113-21
12393847
J Immunol. 2008 Aug 15;181(4):2277-84
18684916
J Immunol. 2000 Nov 1;165(9):5069-76
11046037
Immunity. 2008 Dec 19;29(6):947-57
19100701
Cell Host Microbe. 2008 Oct 16;4(4):337-49
18854238
Gastroenterology. 2005 Sep;129(3):969-84
16143135
Science. 2006 Nov 17;314(5802):1157-60
17110582
Eur J Immunol. 2007 Sep;37(9):2396-9
17694576
Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):289-94
19075782
Clin Dev Immunol. 2008;2008:416910
18389070
J Exp Med. 2004 Feb 2;199(3):411-6
14744993
J Clin Invest. 2008 Feb;118(2):534-44
18172556
Mech Dev. 1999 Apr;82(1-2):119-30
10354476
Semin Immunol. 1995 Oct;7(5):335-42
8580465
J Immunol. 1994 Apr 1;152(7):3282-93
7511642
J Immunol. 1997 Mar 1;158(5):2099-106
9036954
Gastroenterology. 2009 Oct;137(4):1391-402.e1-6
19632226
Mech Dev. 1997 Feb;62(1):67-78
9106168
J Immunol. 2007 Sep 15;179(6):3724-33
17785809
J Exp Med. 2008 Sep 29;205(10):2191-8
18762568
Immunity. 2004 Oct;21(4):527-38
15485630
Gastroenterology. 2001 Dec;121(6):1428-36
11729122
Inflamm Bowel Dis. 2008 Apr;14(4):437-45
18088064
Gastroenterology. 2009 Jan;136(1):257-67
18992745
Eur J Immunol. 2000 Jan;30(1):262-71
10602049
Semin Immunol. 2009 Feb;21(1):28-35
18804386
Immunol Rev. 2008 Dec;226:57-79
19161416
J Clin Invest. 1993 Jul;92(1):372-80
7686922
Gastroenterology. 2008 Jun;134(7):2025-35
18439426
N Engl J Med. 2005 Nov 3;353(18):1912-25
16267322
Mucosal Immunol. 2009 Mar;2(2):173-83
19129757
Cell. 1993 Jul 16;74(1):185-95
7687523
J Immunol. 2002 Mar 15;168(6):2811-9
11884450
Science. 2007 Jul 13;317(5835):256-60
17569825
Methods Enzymol. 1986;123:112-24
3702709
J Exp Med. 2000 Sep 4;192(5):761-8
10974041
Trends Immunol. 2008 Nov;29(11):514-22
18838302
Nat Immunol. 2008 Sep;9(9):981-7
18711435
Crit Rev Immunol. 2008;28(4):269-79
19166380